Speaker:Christopher Hobbs. Reviews over 250 clinical trials on the efficacy and safety of cannabis use for glaucoma, HIV/AIDs, opiate addiction, nausea, cancer-related cachexia, muscle spasms, epilepsy, pain, autoimmune diseases and inflammation. The benefits and drawbacks of different delivery systems, different solvents for extraction and vaporizers are discussed. Clinically relevant details on the chemistry, pharmacology, pharmacokinetics and pharmacodynamics of cannabinoids, including THC and CBD, are summarized.